Hints and tips:
Related Special Reports
...Rivals AstraZeneca, Johnson & Johnson, Russia’s Sputnik V and new entrants such as Novavax make up the remainder of the market, which is forecast to double in value to $124bn next year....
...The AU will pay $6.75 a dose for the BioNTech/Pfizer vaccine and $10 for Johnson & Johnson’s, a single-dose product....
...Mr Baker declined to comment on the leaked note, but later struck a more conciliatory note on Twitter....
...After such strong reads from the first two releases (three if we count Russia’s Sputnik V), the disappointing AZN figures were perhaps bound to prompt downward pressure on the company’s shares....
...In August, Russia became the first country to approve a Covid-19 vaccine — named Sputnik V — for civilian use, but western experts cast doubt on its efficacy and safety....
...Alan Baker, a retired Israeli diplomat who negotiated the Oslo Accord articles that relate to healthcare, said such collaboration was built into the treaty....
...Brunswick Group hired former Pfizer China government affairs vice-president Xi Qing as a partner in Asia....
...US outfits such as Cadwalader, Wickersham & Taft, Reed Smith, BCLP and Baker McKenzie have moved swiftly to cut both payouts for partners and salaries for more junior lawyers — going further than most UK...
...JPMorgan Chase analyst Jamie Baker, in a recent note, said: “October 1 is likely to emerge as one of the darkest days in history for airline labour.”...
...Baker Botts has hired Gaye Lentz as a partner in the law firm’s global projects department in Austin. Lentz joins from Thompson & Knight....
...According to Baker Hughes, the oil and gas rig count in the US reached a new record low of 339 last week (its lowest level since at least 1940)....
...Last year, for example, Halliburton and Baker Hughes scrapped their $28bn marriage while Pfizer abandoned a $160bn takeover of Allergan....
...Just weeks before that, proposed rules from the White House aimed at deterring so-called tax inversions caused Pfizer to scrap its planned buyout of Allergan....
...Those three deals (Comcast/Time Warner Cable, Halliburton/Baker Hughes, and Pfizer/Allergan) ran into regulatory problems and were blocked — all, in retrospect, entirely predictably....
...These efforts saw Pfizer abandon its $160bn pursuit of botox maker Allergan....
...HBC had considered an acquisition of V&D, but Mr Baker had deemed it “not fixable” after “too many years” of decline. “We went in a different direction,” he added....
...The White House’s efforts to deter tax inversion deals saw Pfizer abandon its $160bn pursuit of botox maker Allergan on Wednesday....
...This year alone, the DoJ has torpedoed a $38bn merger between oilfield services companies Halliburton and Baker Hughes, while new tax rules introduced in 2016 by the government forced Pfizer to jettison...
...A $28bn planned merger between oilfield services companies Halliburton and Baker Hughes was sunk by regulators who sued in an attempt to stop the deal....
...While Pfizer was projected to finance its takeover primarily with stock and cash, Halliburton last year raised $7.5bn for its acquisition of Baker Hughes....
...The US Department of Justice sued to block Halliburton’s proposed $25bn takeover of rival oil services group Baker Hughes....
...The US government cited antitrust concerns this week when it filed a lawsuit to block the proposed $25bn takeover by oil services group Halliburton of its rival Baker Hughes....
...Drugmaker Pfizer scrapped its $160bn bid for Allergan; the US government sued to block Halliburton’s $25bn takeover of Baker Hughes; and Anbang Insurance walked away from a $14bn offer for Starwood Hotels...
...Halliburton and Baker Hughes also plan to fight the DoJ....
...Just last month a $28bn planned merger between oilfield services companies Halliburton and Baker Hughes was sunk by the Department of Justice and new tax rules prompted Pfizer to scrap its planned $160bn...
International Edition